Qiming Corporate GP VI, Ltd. sold 72,301 shares of Alamar Biosciences, Inc. at $29.89 for −$2.16M on Nov 3, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
10% owner
10%
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$2,161,076.89Shares × reported price
Shares traded
72,301Common Stock
Price per share
$29.89Reported price. Read footnotes for ranges.
% of reported position traded
1.21%This security and ownership context
Holdings after
5,907,803Indirect · See footnote
Trade date
Nov 3, 2026Sell
Filed
Nov 5, 2026, 4:10 PM ET2-day reporting delay
Accession
0001231919-26-001540Code S · Transaction 393458
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 5,980,104 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 3, 2026Sell1,946$29.89−$58,165.94Trade 393457
Nov 3, 2026Sell16,870$29.89−$504,244.30Trade 393459
Nov 3, 2026Sell20,196$29.89−$603,658.44Trade 393460
4 transaction rows in this filing. Joint filers share the same rows.

ALMR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ALMR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +28%1w ago +19%1d ago +7.6%
Returns since7d +18%30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.40 to $30.22, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote F2: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. F3: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. F4: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. F5: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.